首页 > 市场调查报告书 > 製药

骨疾病

中东和非洲骨关节炎治疗市场预测至 2030 年 - 区域分析 - 按治疗类型、疾病适应症和最终用户

市场调查报告书

商品编码

1562201

中东和非洲骨关节炎治疗市场预测至 2030 年 - 区域分析 - 按治疗类型、疾病适应症和最终用户

Middle East & Africa Osteoarthritis Therapy Market Forecast to 2030 - Regional Analysis - by Therapy Type, Disease Indication, and End User

出版日期: 2024年07月04日 | 出版商:

The Insight Partners | 英文 101 Pages | 订单完成后即时交付

价格

简介目录图表

2022年中东和非洲骨关节炎治疗市场价值为4.600亿美元，预计2030年将达到7.6298亿美元；预计2022年至2030年复合年增长率为6.5%。

骨关节炎盛行率上升推动了中东和非洲骨关节炎治疗市场

根据 CDC 报告，在全球范围内，OA 影响着超过 5 亿人，占世界人口的 7%。它是长期残疾的主要原因。此外，骨关节炎在运动员和遭受关节损伤或创伤的人中也更为常见。此外，女性更为常见，占全球骨关节炎病例的 60%。根据世界卫生组织（WHO）的报告，骨关节炎在老年族群中更为常见。此外，骨关节炎可以影响任何人，但这种情况在 40 岁以上的成年人中最常见。此外，世界卫生组织的报告进一步显示，约73%的骨关节炎患者年龄超过55岁，其中60%是女性。因此，随着 OA 盛行率的上升，生物疗法等新的治疗方案正在全世界受到关注。富血小板血浆 (PRP) 疗法就是一个例子，它已成为治疗 OA 患者的一种有希望的治疗方法。 PRP 透过催化身体的自然癒合和组织修復过程来增强组织恢復。

经皮神经电刺激 (TENS) 是治疗 OA 的另一个例子。 TENS 透过减少对药物的需求来帮助减轻急性和慢性疼痛。因此，骨关节炎盛行率的上升加速了对创新治疗方案的需求，从而在未来几年减少对药物的依赖。

中东和非洲骨关节炎治疗市场概述

中东和非洲地区分为沙乌地阿拉伯、南非、阿联酋以及其他中东和非洲国家。肥胖率上升、生活型态和饮食模式的改变是中东和非洲地区骨关节炎药物需求加速的最重要因素。根据美国国立卫生研究院 (NIH) 的报告，骨关节炎是最常见的关节炎形式。在南非，城市环境中，这一比例占 55.1%；在农村地区，这一比例从 29.5% 到 29.7% 不等，在 65 岁以上人口中这一比例高达 82.7%。医生提出了几种治疗骨关节炎的治疗方案。治疗包括非类固醇抗发炎药 (NSAID)，例如布洛芬。因此，骨关节炎治疗方案的可用性是 2022-2030 年市场成长的主要因素。

中东和非洲骨关节炎治疗市场收入及 2030 年预测（百万美元）

中东和非洲骨关节炎治疗市场区隔

中东和非洲骨关节炎治疗市场按治疗类型、疾病适应症、最终用户和国家分类。

依治疗类型，中东和非洲骨关节炎治疗市场分为经皮神经电刺激（TENS）、职能治疗、物理治疗、富血小板血浆（PRP）治疗和基质血管成分、增生疗法等。 2022 年，物理治疗领域占据最大的市场。

从疾病适应症来看，中东和非洲骨关节炎治疗市场分为膝骨关节炎、脊椎骨关节炎、足踝骨关节炎、肩骨关节炎、手骨关节炎等。 2022 年，膝骨关节炎细分市场在中东和非洲骨关节炎治疗市场中占最大份额。

根据最终用户，中东和非洲骨关节炎治疗市场分为医院和诊所、专科诊所、门诊手术中心、家庭护理等。 2022 年，家庭护理领域在中东和非洲骨关节炎治疗市场中占据最大份额。

按国家/地区划分，中东和非洲骨关节炎治疗市场分为南非、沙乌地阿拉伯、阿联酋以及中东和非洲其他地区。 2022 年，南非在中东和非洲骨关节炎治疗市场份额中占据主导地位。

Estar Technologies Ltd、Zimmer Biomet Holdings Inc、DePuy Synthes Inc、Bioventus Inc、Omron Healthcare Inc 和 Medi GmbH & Co KG 是中东和非洲骨关节炎治疗市场的一些领先公司。

Globally, OA affects more than 500 million people accounting 7% of the world's population according to the CDC report. It represents a major cause of long-term disability. Additionally, osteoarthritis is also more prevalent among athletes and people who sustain joint injury or trauma. Moreover, it is more prevalent among women, accounting for 60% of global osteoarthritis cases. According to the World Health Organization (WHO) report, osteoarthritis is more prevalent among older population. Also, OA can affect anyone, but the condition is most common in adults over 40 years age. Also, The World Health Organization report further reveals that, about 73% of are living with OA are older than 55 years and 60% are female. Thus, with the rising prevalence of OA, new therapy options such as biological therapy are gaining attention worldwide. Platelet-rich plasma (PRP) therapy is one example that has emerged as a promising treatment for patients suffering from OA. PRP enhances tissue recovery by catalyzing the body's natural healing and tissue repair processes.

Transcutaneous Electrical Nerve Stimulation (TENS) is another example of a treatment option to treat OA. TENS helps minimize acute and chronic pains by reducing the need for medications. Therefore, rising prevalence of OA accelerates demand for innovative treatment options, reducing the dependency on medications in the coming years.

Middle East & Africa Osteoarthritis Therapy Market Overview

Middle East & Africa region is segmented as Saudi Arabia, South Africa, UAE, and the Rest of Middle East & Africa countries. The rising obesity rates, alteration in lifestyles, and dietary patterns are the most influential factors responsible for accelerating demand for osteoarthritis drugs in the Middle East & Africa region. According to the National Institute of Health (NIH) report, osteoarthritis is the most prevalent form of arthritis. In South Africa, in urban settings, it accounted for 55.1%; in rural settings, it ranged from 29.5% to 29.7%, reaching up to 82.7% among the population over 65 years. Physicians suggest several therapeutic options to treat osteoarthritis. Treatment includes non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen. Therefore, the availability of treatment options for osteoarthritis is the major factor responsible for the market growth during the 2022-2030.

Middle East & Africa Osteoarthritis Therapy Market Revenue and Forecast to 2030 (US$ Million)

Middle East & Africa Osteoarthritis Therapy Market Segmentation

The Middle East & Africa osteoarthritis therapy market is categorized into therapy type, disease indications, end user, and country.

Based on therapy type, the Middle East & Africa osteoarthritis therapy market is segmented into transcutaneous electrical nerve stimulation (TENS), occupational therapy, physical therapy, platelet-rich plasma (PRP) therapy & stromal vascular fraction, prolotherapy, and others. The physical therapy segment held the largest market share in 2022.

In terms of disease indications, the Middle East & Africa osteoarthritis therapy market is segmented into knee osteoarthritis, spine osteoarthritis, foot and ankle osteoarthritis, shoulder osteoarthritis, hand osteoarthritis, and others. The knee osteoarthritis segment held the largest share of Middle East & Africa osteoarthritis therapy market in 2022.

Based on end user, the Middle East & Africa osteoarthritis therapy market is categorized into hospitals and clinics, specialty clinics, ambulatory surgical center, homecare, and others. The homecare segment held the largest share of Middle East & Africa osteoarthritis therapy market in 2022.

By country, the Middle East & Africa osteoarthritis therapy market is segmented into South Africa, Saudi Arabia, the UAE, and the Rest of Middle East & Africa. South Africa dominated the Middle East & Africa osteoarthritis therapy market share in 2022.

Estar Technologies Ltd, Zimmer Biomet Holdings Inc, DePuy Synthes Inc, Bioventus Inc, Omron Healthcare Inc, and Medi GmbH & Co KG are some of the leading companies operating in the Middle East & Africa osteoarthritis therapy market.

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Osteoarthritis Therapy Market Landscape

4.1 Pipeline Analysis
- 4.1.1 Clinical Trial Pipeline Analysis

5. Middle East & Africa Osteoarthritis Therapy Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Prevalence of Osteoarthritis
- 5.1.2 Innovative Therapy Options Reducing Dependency on Medications
5.2 Market Restraints
- 5.2.1 Product Recall
5.3 Market Opportunities
- 5.3.1 Availability of Regenerative Medicine
5.4 Future Trends
- 5.4.1 More Effective Treatment Options
5.5 Impact of Drivers and Restraints:

6. Osteoarthritis Therapy Market - Middle East & Africa Market Analysis

6.1 Overview
- 6.1.1 Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030

7. Middle East & Africa Osteoarthritis Therapy Market Analysis - by Therapy Type

7.1 Overview
7.2 Transcutaneous Electrical Nerve Stimulation (TENS)
- 7.2.1 Overview
- 7.2.2 Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Occupational Therapy
- 7.3.1 Overview
- 7.3.2 Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Physical Therapy
- 7.4.1 Overview
- 7.4.2 Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.5 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction
- 7.5.1 Overview
- 7.5.2 Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.6 Prolotherapy
- 7.6.1 Overview
- 7.6.2 Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
7.7 Others
- 7.7.1 Overview
- 7.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

8. Middle East & Africa Osteoarthritis Therapy Market Analysis - by Disease Indication

8.1 Overview
8.2 Knee Osteoarthritis
- 8.2.1 Overview
- 8.2.2 Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Spine Osteoarthritis
- 8.3.1 Overview
- 8.3.2 Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Foot and Ankle Osteoarthritis
- 8.4.1 Overview
- 8.4.2 Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Shoulder Osteoarthritis
- 8.5.1 Overview
- 8.5.2 Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Hand Osteoarthritis
- 8.6.1 Overview
- 8.6.2 Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

9. Middle East & Africa Osteoarthritis Therapy Market Analysis - by End User

9.1 Overview
9.2 Hospitals and Clinics
- 9.2.1 Overview
- 9.2.2 Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Specialty Clinics
- 9.3.1 Overview
- 9.3.2 Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Ambulatory Surgical Centers
- 9.4.1 Overview
- 9.4.2 Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.5 Homecare
- 9.5.1 Overview
- 9.5.2 Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
9.6 Others
- 9.6.1 Overview
- 9.6.2 Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)

10. Middle East & Africa Osteoarthritis Therapy Market - Country Analysis

10.1 Middle East & Africa Market Overview
- 10.1.1 Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.1 Overview
    - 10.1.1.1.2 South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.1.3 South Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.1.4 South Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.1.5 South Africa: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.1 Overview
    - 10.1.1.2.2 Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.2.3 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.2.4 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.2.5 Saudi Arabia: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.3 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.1 Overview
    - 10.1.1.3.2 United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.3.3 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.3.4 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.3.5 United Arab Emirates: Osteoarthritis Therapy Market Breakdown, by End User
  - 10.1.1.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.1 Overview
    - 10.1.1.4.2 Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
    - 10.1.1.4.3 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Therapy Type
    - 10.1.1.4.4 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Disease Indication
    - 10.1.1.4.5 Rest of Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in the osteoarthritis therapy market
11.3 Organic Developments
- 11.3.1 Overview
11.4 Inorganic Developments
- 11.4.1 Overview

12. Company Profiles

12.1 Estar Technologies Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Zimmer Biomet Holdings Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 DePuy Synthes Inc
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Bioventus Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Omron Healthcare Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Medi GmbH & Co KG
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments

13. Appendix

13.1 About the Insight Partners

简介目录图表

List Of Tables

Table 1. Osteoarthritis Therapy Market Segmentation
Table 2. Ongoing Clinical Trial of Osteoarthritis
Table 3. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 4. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 5. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 6. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 7. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 8. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 9. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 10. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 11. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 12. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Therapy Type
Table 13. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by Disease Indication
Table 14. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Organic Developments Done by Companies
Table 16. Inorganic Developments Done by Companies

List Of Figures

Figure 1. Osteoarthritis Therapy Market Segmentation, by Country
Figure 2. Osteoarthritis Therapy Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Osteoarthritis Therapy Market Revenue (US$ Million), 2020-2030
Figure 5. Osteoarthritis Therapy Market Share (%) - by Therapy Type (2022 and 2030)
Figure 6. Transcutaneous Electrical Nerve Stimulation (TENS): Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Occupational Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Physical Therapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Platelet-Rich Plasma Therapy and Stromal Vascular Fraction: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 10. Prolotherapy: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Osteoarthritis Therapy Market Share (%) - by Disease Indication (2022 and 2030)
Figure 13. Knee Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 14. Spine Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Foot and Ankle Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Shoulder Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Hand Osteoarthritis: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Osteoarthritis Therapy Market Share (%) - by End User (2022 and 2030)
Figure 20. Hospitals and Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Specialty Clinics: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Ambulatory Surgical Centers: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Homecare: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 24. Others: Osteoarthritis Therapy Market - Revenue and Forecast to 2030 (US$ Million)
Figure 25. Middle East & Africa: Osteoarthritis Therapy Market - Revenue by Key Countries 2022 (US$ Million)
Figure 26. Middle East & Africa: Osteoarthritis Therapy Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 27. South Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Saudi Arabia: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. United Arab Emirates: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Middle East & Africa: Osteoarthritis Therapy Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Osteoarthritis Therapy Market